Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Tuesday, April 13, 2021
NIH trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins | National Institutes of Health (NIH)
NIH trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins | National Institutes of Health (NIH): The study will enroll between 300 and 350 hospitalized COVID-19 patients aged 18 years or older at 10 to 15 sites nationwide.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment